Second Sight Medical Products Aktie

Second Sight Medical Products für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A3DTRX / ISIN: US92854B1098

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
11.06.2025 14:29:10

Vivani Medical Appoints Anthony Baldor To Succeed Brigid Makes As CFO

(RTTNews) - Vivani Medical, Inc. (VANI), a clinical-stage biopharmaceutical company, announced Wednesday the appointment of Anthony Baldor as Chief Financial Officer.

Baldor succeeds Brigid Makes, who has decided to retire from Vivani to focus on her board appointments and personal projects after a distinguished career and significant contributions to the Company. Makes will continue to serve in an advisory capacity during the transition.

Baldor brings more than 20 years of financial management experience in the biotechnology sector. Prior to joining Vivani, Baldor was CFO at Diakonos Oncology Corp., and Vice President of Corporate Strategy & Development at 4D Molecular Therapeutics, Inc.

His experience also includes positions at Jefferies Group LLC, BioInnovation Capital, LLC, RMI Partners, and Cequent Pharmaceuticals, Inc.

Nachrichten zu Second Sight Medical Products Inc Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Second Sight Medical Products Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel